PDGFRA and gastrointestinal stromal tumor: Activating mutations in KIT or platelet-derived growth factor receptor alpha (PDGFRA) have been identified in up to 80% and 10% of GISTs, respectively, and these mutually exclusive gain-of-function mutations play a fundamental role in GIST development by constitutively activating tyrosine kinase receptors [1–6].